Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hercules Technology Growth Capital (NY: HTGC )

14.47 -0.23 (-1.56%)
Official Closing Price Updated: 7:00 PM EST, Feb 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 716,357
Open 14.65
Bid (Size) 14.47 (20)
Ask (Size) 14.86 (1)
Prev. Close 14.70
Today's Range 14.45 - 14.78
52wk Range 11.16 - 19.09
Shares Outstanding N/A
Dividend Yield 1.38%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2022 Financial Results and Conference Call
From Hercules Capital, Inc.
Via Business Wire
AmplifyBio Secures $50M in Debt Financing With Hercules Capital to Accelerate Business Plan
AmplifyBio announces $50M in debt financing to accelerate the expansion of its service offering, supporting the rapid, safe development of next-generation therapeutics 
Via Newswire.com

Performance

YTD
+8.80%
+8.80%
1 Month
+7.26%
+7.26%
3 Month
+3.28%
+3.28%
6 Month
-6.71%
-6.71%
1 Year
-19.52%
-19.52%

More News

Read More
Hercules Capital Announces Upcoming Event for the Financial Community
From Hercules Capital, Inc.
Via Business Wire
Expert Ratings for Hercules Capital
Via Benzinga
IVERIC bio Shares Jump On Debt Financing To Fund Zimura Launch
Via Benzinga
Daily Stock Analysis: Hercules Capital Inc.
Via Talk Markets
Hercules Capital Announces Upcoming Events for the Financial Community
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Reports Third Quarter 2022 Financial Results
From Hercules Capital, Inc.
Via Business Wire
Phathom Pharmaceuticals Announces Placement of the Remaining $40 Million in Non-Dilutive Capital under its up to $300 Million Revenue Interest Financing Agreement
From Phathom Pharmaceuticals
Via Globe NewsWire
As Small Caps Rally, These 3 Finance High-Yielders Could Have Further Upside
Via Benzinga
4 Analysts Have This to Say About Hercules Capital
Via Benzinga
Hercules Capital Announces Date for Release of Third Quarter 2022 Financial Results and Conference Call
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the Third Quarter of 2022
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Increases Its Quarterly Cash Distribution to $0.36 per Share for the Third Quarter of 2022
From Hercules Capital, Inc.
Via Business Wire
Replimune Gets 33% Price Target Bump Ahead Of Upcoming Readouts. Analyst Lists The Catalysts
Via Benzinga
The 2 Best Stocks For Even Higher Interest Rates
Via Talk Markets
Hercules Receives a BBB+ Reaffirmed Investment Grade Corporate Rating from Kroll Bond Rating Agency, Inc.
From Hercules Capital, Inc.
Via Business Wire
Major Goals For ATAI: $175M Secured In Term Loan Facility, Plus Q2 Earnings Report
Via Benzinga
The 2 Best Stocks For The 2022 Recession
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022
Via Benzinga
Hercules Capital Reports Second Quarter 2022 Financial Results
From Hercules Capital, Inc.
Via Business Wire
Earnings Preview For Hercules Capital
Via Benzinga
Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate
Via Benzinga
Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the Second Quarter of 2022
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Increases Its Quarterly Cash Distribution to $0.35 per Share for the Second Quarter of 2022
From Hercules Capital, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.